A second dose of HER2-XPAT protein 50 mg kg−1 led to toxicity in one of two NHPs dosed, manifesting as multiple findings, including evidence of decreased cellularity in lymphoid tissues, moderate-to-severe colonic inflammation associated with infection with intralesional protozoa and bacterial pneumonia. This evidence concerns the gene ERBB2 and bacterial pneumonia.